{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-11764"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-11764","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"3D Organ-Scale Models of Tumor Growth and Treatment","abstract":"To understand the dynamics of cancer, mathematical oncologists have developed models of tumor growth and treatment response. Some models are mechanistic and approach tumor growth at the cell-scale, focusing on the evolution of cancerous cells within the ecology of normal tissue, and are often simulated with agent-based modeling. Other models are more clinically motivated and model tumor growth operating at the organ-scale, using patient data to predict treatment response, and are often simulated with partial differential equations. We developed the Hybrid Automata Library which includes both agent-based modeling and partial differential equations for modeling at either of these scales. We further aimed to bridge these scales by developing the population-based modeling method. This novel method applies probabilistic rules to discrete cell counts with cubic millimeter spatial resolution, thus linking mechanistic cell-scale dynamics to clinically observable organ-scale tumor growth. We have applied this method to early stage non-small cell lung cancer to explore the effect of normal tissue density on tumor growth. We found that high density tissue causes the tumor cells to become more glycolytic, while low density tissue causes the tumor cells to become more angiogenic. We then fit the model to pre-cancerous lesions from the National Lung Screening Trial, and supported that lesions in low-density tissue appear angiogenic. We extended the model to simulate adaptive therapy and studied the impact of monitoring the tumor using imaging compared to using a blood biomarker. We found that blood biomarker guided adaptive therapy extends time to progression by providing better control of the sensitive population, but it does not control the spread of the tumor cells spatially as much as imaging guided adaptive therapy. We also studied how tissue properties measured via MRI sequences impact glioblastoma by implementing another novel method using convolution to propagate the segmented tumor region. We found that the FLAIR sequence is highly correlated with both the tumor growth trajectory and where it will survive immunotherapy. The implications of these models present new insights into improving patient-specific therapy and are supported by/verifiable with imaging data.","abstract_html":"To understand the dynamics of cancer, mathematical oncologists have developed models of tumor growth and treatment response. Some models are mechanistic and approach tumor growth at the cell-scale, focusing on the evolution of cancerous cells within the ecology of normal tissue, and are often simulated with agent-based modeling. Other models are more clinically motivated and model tumor growth operating at the organ-scale, using patient data to predict treatment response, and are often simulated with partial differential equations. We developed the Hybrid Automata Library which includes both agent-based modeling and partial differential equations for modeling at either of these scales. We further aimed to bridge these scales by developing the population-based modeling method. This novel method applies probabilistic rules to discrete cell counts with cubic millimeter spatial resolution, thus linking mechanistic cell-scale dynamics to clinically observable organ-scale tumor growth. We have applied this method to early stage non-small cell lung cancer to explore the effect of normal tissue density on tumor growth. We found that high density tissue causes the tumor cells to become more glycolytic, while low density tissue causes the tumor cells to become more angiogenic. We then fit the model to pre-cancerous lesions from the National Lung Screening Trial, and supported that lesions in low-density tissue appear angiogenic. We extended the model to simulate adaptive therapy and studied the impact of monitoring the tumor using imaging compared to using a blood biomarker. We found that blood biomarker guided adaptive therapy extends time to progression by providing better control of the sensitive population, but it does not control the spread of the tumor cells spatially as much as imaging guided adaptive therapy. We also studied how tissue properties measured via MRI sequences impact glioblastoma by implementing another novel method using convolution to propagate the segmented tumor region. We found that the FLAIR sequence is highly correlated with both the tumor growth trajectory and where it will survive immunotherapy. The implications of these models present new insights into improving patient-specific therapy and are supported by/verifiable with imaging data.","abstract_has_math":false,"creators":["Bravo, Rafael Ramon"],"institution":"University of South Florida","degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":["Alexander Anderson, Ph.D.","Thomas Yankeelov, Ph.D.","David Basanta, Ph.D.","Amer Beg, Ph.D.","Robert Gatenby, Ph.D.","Heiko Enderling, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-06-28T07:00:00Z","date_published":"2024-06-28T07:00:00Z","updated_at":"2026-11-19T08:50:14Z","subjects":["bridging-scales","host-tumor interaction","mathematical oncology","population-based modeling","volumetric imaging","Applied Mathematics","Computer Sciences","Oncology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/10477","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/10477","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-11764","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Alexander Anderson, Ph.D.","Thomas Yankeelov, Ph.D.","David Basanta, Ph.D.","Amer Beg, Ph.D.","Robert Gatenby, Ph.D.","Heiko Enderling, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Bravo, Rafael Ramon"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-06-28T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["bridging-scales","host-tumor interaction","mathematical oncology","population-based modeling","volumetric imaging","Applied Mathematics","Computer Sciences","Oncology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/10477"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["To understand the dynamics of cancer, mathematical oncologists have developed models of tumor growth and treatment response. Some models are mechanistic and approach tumor growth at the cell-scale, focusing on the evolution of cancerous cells within the ecology of normal tissue, and are often simulated with agent-based modeling. Other models are more clinically motivated and model tumor growth operating at the organ-scale, using patient data to predict treatment response, and are often simulated with partial differential equations. We developed the Hybrid Automata Library which includes both agent-based modeling and partial differential equations for modeling at either of these scales. We further aimed to bridge these scales by developing the population-based modeling method. This novel method applies probabilistic rules to discrete cell counts with cubic millimeter spatial resolution, thus linking mechanistic cell-scale dynamics to clinically observable organ-scale tumor growth. We have applied this method to early stage non-small cell lung cancer to explore the effect of normal tissue density on tumor growth. We found that high density tissue causes the tumor cells to become more glycolytic, while low density tissue causes the tumor cells to become more angiogenic. We then fit the model to pre-cancerous lesions from the National Lung Screening Trial, and supported that lesions in low-density tissue appear angiogenic. We extended the model to simulate adaptive therapy and studied the impact of monitoring the tumor using imaging compared to using a blood biomarker. We found that blood biomarker guided adaptive therapy extends time to progression by providing better control of the sensitive population, but it does not control the spread of the tumor cells spatially as much as imaging guided adaptive therapy. We also studied how tissue properties measured via MRI sequences impact glioblastoma by implementing another novel method using convolution to propagate the segmented tumor region. We found that the FLAIR sequence is highly correlated with both the tumor growth trajectory and where it will survive immunotherapy. The implications of these models present new insights into improving patient-specific therapy and are supported by/verifiable with imaging data."]},{"key":"dc:title","label":"Title","values":["3D Organ-Scale Models of Tumor Growth and Treatment"]}]}],"canonical_facts":{"dc:contributor":["Alexander Anderson, Ph.D.","Thomas Yankeelov, Ph.D.","David Basanta, Ph.D.","Amer Beg, Ph.D.","Robert Gatenby, Ph.D.","Heiko Enderling, Ph.D."],"dc:creator":["Bravo, Rafael Ramon"],"dc:date":["2024-06-28T07:00:00Z"],"dc:description":["To understand the dynamics of cancer, mathematical oncologists have developed models of tumor growth and treatment response. Some models are mechanistic and approach tumor growth at the cell-scale, focusing on the evolution of cancerous cells within the ecology of normal tissue, and are often simulated with agent-based modeling. Other models are more clinically motivated and model tumor growth operating at the organ-scale, using patient data to predict treatment response, and are often simulated with partial differential equations. We developed the Hybrid Automata Library which includes both agent-based modeling and partial differential equations for modeling at either of these scales. We further aimed to bridge these scales by developing the population-based modeling method. This novel method applies probabilistic rules to discrete cell counts with cubic millimeter spatial resolution, thus linking mechanistic cell-scale dynamics to clinically observable organ-scale tumor growth. We have applied this method to early stage non-small cell lung cancer to explore the effect of normal tissue density on tumor growth. We found that high density tissue causes the tumor cells to become more glycolytic, while low density tissue causes the tumor cells to become more angiogenic. We then fit the model to pre-cancerous lesions from the National Lung Screening Trial, and supported that lesions in low-density tissue appear angiogenic. We extended the model to simulate adaptive therapy and studied the impact of monitoring the tumor using imaging compared to using a blood biomarker. We found that blood biomarker guided adaptive therapy extends time to progression by providing better control of the sensitive population, but it does not control the spread of the tumor cells spatially as much as imaging guided adaptive therapy. We also studied how tissue properties measured via MRI sequences impact glioblastoma by implementing another novel method using convolution to propagate the segmented tumor region. We found that the FLAIR sequence is highly correlated with both the tumor growth trajectory and where it will survive immunotherapy. The implications of these models present new insights into improving patient-specific therapy and are supported by/verifiable with imaging data."],"dc:identifier":["https://digitalcommons.usf.edu/etd/10477"],"dc:subject":["bridging-scales","host-tumor interaction","mathematical oncology","population-based modeling","volumetric imaging","Applied Mathematics","Computer Sciences","Oncology"],"dc:title":["3D Organ-Scale Models of Tumor Growth and Treatment"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:50:14Z"}